BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 28751023)

  • 21. HSP27 regulates TGF-β mediated lung fibroblast differentiation through the Smad3 and ERK pathways.
    Wang G; Jiao H; Zheng JN; Sun X
    Int J Mol Med; 2017 Jan; 39(1):183-190. PubMed ID: 27909724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation.
    Huang C; Xiao X; Yang Y; Mishra A; Liang Y; Zeng X; Yang X; Xu D; Blackburn MR; Henke CA; Liu L
    J Biol Chem; 2017 Oct; 292(40):16420-16439. PubMed ID: 28726637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation.
    Stock CJW; Michaeloudes C; Leoni P; Durham AL; Mumby S; Wells AU; Chung KF; Adcock IM; Renzoni EA; Lindahl GE
    Biomed Res Int; 2019; 2019():1484736. PubMed ID: 31119153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
    Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GRK2 promotes activation of lung fibroblast cells and contributes to pathogenesis of pulmonary fibrosis through increasing Smad3 expression.
    Li Y; Sun Y; Wu N; Ma H
    Am J Physiol Cell Physiol; 2022 Jan; 322(1):C63-C72. PubMed ID: 34852209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts.
    Cucoranu I; Clempus R; Dikalova A; Phelan PJ; Ariyan S; Dikalov S; Sorescu D
    Circ Res; 2005 Oct; 97(9):900-7. PubMed ID: 16179589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium Arsenite Inhibits Lung Fibroblast Differentiation and Pulmonary Fibrosis.
    Jiao H; Song J; Sun X; Sun D; Zhong M
    Pharmacology; 2019; 104(5-6):368-376. PubMed ID: 31553994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evogliptin attenuates bleomycin-induced lung fibrosis via inhibiting TGF-β/Smad signaling in fibroblast.
    Ba YD; Sun JH; Zhao XX
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10790-10798. PubMed ID: 33155239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.
    Xiao X; Senavirathna LK; Gou X; Huang C; Liang Y; Liu L
    Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27582065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of dimethyl itaconate against fibroblast-myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP.
    Han YY; Gu X; Yang CY; Ji HM; Lan YJ; Bi YQ; Si R; Qu J; Cheng MH; Gao J
    J Cell Physiol; 2021 Nov; 236(11):7734-7744. PubMed ID: 34061990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
    Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
    J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
    Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
    Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced pluripotent stem cell-conditioned medium suppresses pulmonary fibroblast-to-myofibroblast differentiation via the inhibition of TGF-β1/Smad pathway.
    Zhou Y; Zhang Q; Gao Y; Tan M; Zheng R; Zhao L; Zhang X
    Int J Mol Med; 2018 Jan; 41(1):473-484. PubMed ID: 29115383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.
    Pan X; Li J; Tu X; Wu C; Liu H; Luo Y; Dong X; Li X; Pan LL; Sun J
    Pharmacol Res; 2020 Feb; 152():104592. PubMed ID: 31830521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4.
    Zhang D; Liu B; Cao B; Wei F; Yu X; Li GF; Chen H; Wei LQ; Wang PL
    Int Immunopharmacol; 2017 Jul; 48():67-75. PubMed ID: 28476015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-β activation impairs fibroblast ability to support adult lung epithelial progenitor cell organoid formation.
    Ng-Blichfeldt JP; de Jong T; Kortekaas RK; Wu X; Lindner M; Guryev V; Hiemstra PS; Stolk J; Königshoff M; Gosens R
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L14-L28. PubMed ID: 30969812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of lncRNA PFRL prevents pulmonary fibrosis by disrupting the miR-26a/smad2 loop.
    Jiang H; Chen Y; Yu T; Zhao X; Shan H; Sun J; Zhang L; Li X; Shan H; Liang H
    Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L563-L575. PubMed ID: 29952219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
    Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
    J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.